Fusen Pharmaceutical Company Limited (1652.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 531.24M |
| Enterprise Value | 771.71M |
| P/E Ratio | -57.4 |
| PEG Ratio | -0.53 |
| Price/Sales Ratio | 2.5 |
| Price/Book Ratio | 2.08 |
| Enterprise/Revenue | 3.38 |
| Enterprise/EBITDA | 40.78 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.04 |
| Operating Margin | -0.01 |
AD
Management Effectiveness
| Return On Assets | -0.01 |
| Return On Equity | -0.03 |
Income Statement
| Revenue | 273.37M |
| Revenue/Share | 0.34 |
| Gross Profit | 109.79M |
| EBITDA | 11.55M |
| Net Income | -11.78M |
| Diluted EPS | -0.02 |
Balance Sheet
| Total Cash | 83.88M |
| Total Cash/Share | 0.1 |
| Total Debt | 324.34M |
| Total Debt/Equity | 0.9 |
| Current Ratio | 0.56 |
| Book Value Per Share | 0.46 |
Price History
| 52-Week Change | 229.23 |
| 52-Week High | 1.75 |
| 52-Week Low | 0.3 |
| Moving Average 50 Days | 1.12 |
| Moving Average 200 Days | 0.93 |
Statistics
| Average Volume | 257,067 |
| Shares Outstanding | 739.3M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
